🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

PlasmaGen Biosciences raises Rs 150 Cr led by ViNS Bioproducts

EntrackrEntrackr · 1m ago
PlasmaGen Biosciences raises Rs 150 Cr led by ViNS Bioproducts
Medial

Snippets PlasmaGen Biosciences raises Rs 150 Cr led by ViNS Bioproducts Bengaluru-based biopharma company PlasmaGen Biosciences has raised Rs 150 crore led by ViNS Bioproducts along with participation from high-net-worth individuals, family offices, pharma entrepreneurs, and existing investors. The startup is backed by Eight Road Ventures secured the funding at a valuation of over Rs 1,500 crore. PlasmaGen has mopped up over Rs 600 crore in funding to date from Fidelity's FIL Capital Investments, Eight Roads Ventures, F-Prime Capital, and others. The proceeds will be used to scale international operations, expand the product portfolio, and strengthen manufacturing and leadership capabilities, PlasmaGen Biosciences said in a press release. Founded in 2010, PlasmaGen Biosciences focuses on producing and marketing plasma-derived therapies like Immunoglobulin, Albumin, and clotting factors to bridge India's demand-supply gap for these critical medicines, operating a modern fractionation plant in Kolar, Karnataka, and serving neurology, hematology, and critical care, aiming for self-reliance in plasma products. According to PlasmaGen, it has identified distribution partners in key export geographies and is in the process of securing regulatory approvals to begin international sales. India continues to remain a key market for the firm, which is expanding its services across hospitals and physicians through a cold-chain-backed distribution network. PlasmaGen says that it began commercial operations in 2024 at its plasma fractionation facility in Kolar, near Bengaluru. The company asserts that the setup is among only five such facilities in the country and claims that it is the first pure-play plasma biopharma player, has reported strong revenue growth since launch of operations at Kolar and is now preparing to enter overseas markets.

Sindhuja Microcredit raises Rs 120 Cr in Series C round

EntrackrEntrackr · 1y ago
Sindhuja Microcredit raises Rs 120 Cr in Series C round
Medial

New generation microfinance firm Sindhuja Microcredit has raised $14.5 million (Rs 120 crore) in its Series C round from GAWA Capital (through its vehicle Huruma Fund) and Oikocredit. Earlier to this round, the company had raised a Series B funding round of $8.7 million from Norway-based Nordic Microfinance Initiative (NMI) and Carpediem Capital in May 2020. It closed its Series A round of $4 million from Carpediem Capital in March 2019. The new proceeds will be used to expand the business in its existing and new geographies as well as new product lines, the company said in a press release. Promoted by Abhisheka Kumar and Malkit Singh Didyala, Sindhuja Microcredit provides microfinance to skilled women entrepreneurs who lack capital. The Noida-based company also provides business loans to traders, shopkeepers and farmers for working capital needs or for expanding their businesses. Within six years of operation, Sindhuja claims to have provided micro-loans to over 400,000 self-employed women micro-entrepreneurs across nine states in northern, eastern and western parts of India. The company currently operates 235 branches with over Rs 10 billion in Assets under Management (AUM).

Care.fi secures Rs 7.5 Cr in debt from Vivriti Capital

EntrackrEntrackr · 10m ago
Care.fi secures Rs 7.5 Cr in debt from Vivriti Capital
Medial

Care.fi secures Rs 7.5 Cr in debt from Vivriti Capital Healthcare-focused fintech startup Care.fi has secured Rs 7.5 crore in debt capital from Vivriti Capital. This latest investment follows its previous funding rounds, which included Rs 8 crore in debt capital raised from Wint Wealth and Caspian, along with $2.5 million (around Rs 21 crore) in debt from Trifecta Capital and UC Inclusive Credit. In total, the group has raised approximately Rs 29 crore to date. The fresh funding will be utilized to accelerate its aim to empower Revenue Cycle Management (RCM) for hospitals and expand the reach of RevNow, Care.fi said in a press release. Co-founded in 2021 by Sidak Singh and Vikrant Agarwal, Care.fi aims to weed out the hassles of insurance claims, which remain a complex challenge for hospitals, often leading to delayed discharges, revenue leakages, and operational inefficiencies. According to the Gurugram-based company, its AI-driven RCM platform, RevNow, is making a significant impact by expediting claim settlements and ensuring hospitals receive payments within 3–5 days post-discharge. It enables 30-minute patient discharges by automating final billing and approvals, drastically reducing wait times. RevNow optimizes hospital workflows with real-time query notifications, automated responses, and integrated mailing services. It also enhances financial transparency by providing real-time reconciliation of cash flows at the entity, unit, and claim levels, offering hospitals greater visibility. “Since our inception, we have focused on solving critical operational pain points in hospital revenue management. With RevNow, we are setting new benchmarks in claims processing efficiency. This latest funding will enable us to scale further, helping hospitals optimize financial workflows while ensuring better patient experiences. As the healthcare ecosystem grows, we aim to continue innovating and improving revenue realization for providers,” said Sidak Singh, co-founder of Care.fi. Care.fi claims that it is handling over Rs 800 crore in claims across over 300 hospitals and auditing more than 50,000 claims. The platform also aims to expand RevNow’s capabilities and integrate further with hospital information systems (HIS), electronic health records (EHR), and billing platforms.

Download the medial app to read full posts, comements and news.